GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...
This was the stock's third consecutive day of gains.
After years of controversy, stem cells are on the cusp of cures for conditions like epilepsy and type 1 diabetes.
Regeneron Pharmaceuticals (REGN) expands its focus on eye care with the acquisition of Oxular, a U.K.-based biotech ...
NEW YORK, NY / ACCESSWIRE / January 3, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex ...
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AbbVie (ABBV – Research Report), Palvella ...
Jefferies investment banker Chris Roop discussed the Big Pharma M&A outlook with Business Insider. Check out the types of ...